NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir
Nucleoside analogs (NNA), such as acyclovir (ACV) and ganciclovir (GCV), are widely used as anti-virals to treat herpes virus infection. Here, Nishii et al. show that diphosphatase NUDT15 hydrolyzes ACV and GCV, therewith reducing NNA activity in vitro and link NUDT15 variation to inter-patient vari...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ac367d8e92bf4e2bb684ff635f13452f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ac367d8e92bf4e2bb684ff635f13452f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ac367d8e92bf4e2bb684ff635f13452f2021-12-02T18:34:21ZNUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir10.1038/s41467-021-24509-72041-1723https://doaj.org/article/ac367d8e92bf4e2bb684ff635f13452f2021-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24509-7https://doaj.org/toc/2041-1723Nucleoside analogs (NNA), such as acyclovir (ACV) and ganciclovir (GCV), are widely used as anti-virals to treat herpes virus infection. Here, Nishii et al. show that diphosphatase NUDT15 hydrolyzes ACV and GCV, therewith reducing NNA activity in vitro and link NUDT15 variation to inter-patient variability in ACV and GCV therapeutic effects.Rina NishiiTakanori MizunoDaniel RehlingColton SmithBrandi L. ClarkXujie ZhaoScott A. BrownBrandon SmartTakaya MoriyamaYuji YamadaTatsuo IchinoheMakoto OnizukaYoshiko AtsutaLei YangWenjian YangPaul G. ThomasPål StenmarkMotohiro KatoJun J. YangNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Rina Nishii Takanori Mizuno Daniel Rehling Colton Smith Brandi L. Clark Xujie Zhao Scott A. Brown Brandon Smart Takaya Moriyama Yuji Yamada Tatsuo Ichinohe Makoto Onizuka Yoshiko Atsuta Lei Yang Wenjian Yang Paul G. Thomas Pål Stenmark Motohiro Kato Jun J. Yang NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
description |
Nucleoside analogs (NNA), such as acyclovir (ACV) and ganciclovir (GCV), are widely used as anti-virals to treat herpes virus infection. Here, Nishii et al. show that diphosphatase NUDT15 hydrolyzes ACV and GCV, therewith reducing NNA activity in vitro and link NUDT15 variation to inter-patient variability in ACV and GCV therapeutic effects. |
format |
article |
author |
Rina Nishii Takanori Mizuno Daniel Rehling Colton Smith Brandi L. Clark Xujie Zhao Scott A. Brown Brandon Smart Takaya Moriyama Yuji Yamada Tatsuo Ichinohe Makoto Onizuka Yoshiko Atsuta Lei Yang Wenjian Yang Paul G. Thomas Pål Stenmark Motohiro Kato Jun J. Yang |
author_facet |
Rina Nishii Takanori Mizuno Daniel Rehling Colton Smith Brandi L. Clark Xujie Zhao Scott A. Brown Brandon Smart Takaya Moriyama Yuji Yamada Tatsuo Ichinohe Makoto Onizuka Yoshiko Atsuta Lei Yang Wenjian Yang Paul G. Thomas Pål Stenmark Motohiro Kato Jun J. Yang |
author_sort |
Rina Nishii |
title |
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
title_short |
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
title_full |
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
title_fullStr |
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
title_full_unstemmed |
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
title_sort |
nudt15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ac367d8e92bf4e2bb684ff635f13452f |
work_keys_str_mv |
AT rinanishii nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT takanorimizuno nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT danielrehling nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT coltonsmith nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT brandilclark nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT xujiezhao nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT scottabrown nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT brandonsmart nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT takayamoriyama nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT yujiyamada nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT tatsuoichinohe nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT makotoonizuka nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT yoshikoatsuta nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT leiyang nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT wenjianyang nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT paulgthomas nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT palstenmark nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT motohirokato nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT junjyang nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir |
_version_ |
1718377879902879744 |